Clinical Trial Update: Safety, Pharmacokinetics and Pharmacodynamics of TA-7284 in Type 2 Diabetic Patients [Phase 1, Phase 2]

View source ↗

Summary

The update reports safety, pharmacokinetics, and pharmacodynamics of TA-7284 in adults with Type 2 diabetes mellitus across Phase 1 and Phase 2 studies, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• TA-7284

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-04-28